Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Braxia Scientific Corp C.BRAX

Alternate Symbol(s):  BRAXF

Braxia Scientific Corp. is a Canada-based medical research and telemedicine company with a clinic that provide ketamine treatments for persons with depression and related disorders. Through its medical solutions, it intends to reduce the illness burden of brain-based disorders, such as major depressive disorder, among others. The Company is primarily focused on owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and research activities related to discovering and commercializing novel drugs and delivery methods. It seeks to develop ketamine and derivatives and other psychedelic products from its IP development platform. The Company has clinic operations in the Canadian cities of Mississauga, Kitchener-Waterloo, Ottawa and Montreal. Its subsidiary, Braxia Health, is engaged in offering rapid onset treatments to aid those suffering from several treatment-resistant conditions, such as depression and bipolar disorder.


CSE:BRAX - Post by User

Braxia Scientific Corp > Ticker Change.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1)
•••
Comment by cautiousguyon Mar 24, 2021 9:19pm
209 Views
Post# 32872761

RE:RE:RE:RE:RE:RE:Ticker Change.

RE:RE:RE:RE:RE:RE:Ticker Change.
newcoin wrote: This is very exciting if it's really happening.
We'll be trading again and under a new name.
Altmed is a successful enterprise already. Lead by a world renowned CEO and making money.
Definitely worth waiting for if that is indeed what's happening.
Fingers crossed.


Paid off/out relatives as consultants, a CFO that couldn't seem to do the books or read spread sheets, or assess assets, bored board members who seemed indifferent, useless or perhaps collusional, eight months of a halt, and we end back where we were with Roger the shareholder dogger as the CEO of Altmed now pumping Ketimine and not the mushrooms I was investing in. None of this is what I bought into.  


Like I said before,  Roger and the Board could have/has fart(ed) in your face and you say there is a sweet smell in the breeze. 


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities